If you need more lookups,
subscriptions start at $34 USD/month.
Deb Steiner Location
Boston, MA, US
Deb Steiner Work
2024 -now Vice President, Global Head of Clinical Development and Safety @
2023 -2024 Vice President Clinical Development @
2020 -2022 Clinical Head Global Pain @ Eli Lilly and Company
2018 -2020 Executive Medical Director, Clinical Development @
2018 -2018 Senior Director, Late Stage Clinical Development @
2016 -2018 Medical Director, Late Stage Clinical Development @
2014 -2016 Medical Director, MS Clinical Development @
2005 -2014 Medical Director @
2004 -2005 Director, Scientific Affairs @ Lane Labs, USA, Inc.
1997 -2004 Head of Clinical Research @ RTL, Inc
1991 -1992 Resident, Pediatrics @ Schneider Children's Hospital. Long Island Jewish Medical Center
Deb Steiner Education
Stony Brook University
MS (Management & Policy)
1994-1998
Icahn School of Medicine at Mount Sinai
MD (Medicine)
1987-1991
Vassar College
BA (Science, Technology, & Society/Biochemistry, cum laude)
1983-1987
Deb Steiner Skills
Internal Medicine
Oncology
Medical Affairs
Clinical Development
Pediatrics
Pharmaceutical Industry
Clinical Trials
Clinical Research
Therapeutic Areas
Drug Development
Medical Writing
Neurology
Medicine
Protocol
Biotechnology
Infectious Diseases
Microsoft Excel
Management
Leadership
Research
Treatment
Healthcare Management
Project Management
Public Speaking
Hospitals
Data Analysis
Deb Steiner Summary
Deb Steiner, based in Boston, MA, US, is currently a Vice President, Global Head of Clinical Development and Safety at X4 Pharmaceuticals. Deb Steiner brings experience from previous roles at X4 Pharmaceuticals, Eli Lilly and Company, Sarepta Therapeutics and Biogen. Deb Steiner holds a 1994 - 1998 MS in Management & Policy @ Stony Brook University. With a robust skill set that includes Internal Medicine, Oncology, Medical Affairs, Clinical Development, Pediatrics and more. Deb Steiner has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Deb Steiner?
Find contact details for 700 million professionals.